National Cancer Institute
Aug. 23, 2016—The National Cancer Institute has announced the Outstanding Investigator Award funding opportunity. The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for seven years to provide funding stability.
VICC researchers to study reasons for high breast cancer incidence and mortality rates among African-American women
Jul. 6, 2016—A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.
Oct. 29, 2015—Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.
Sep. 17, 2015—Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG).
Sep. 11, 2015—Vanderbilt may submit more than one application to this program, provided each is scientifically distinct.
Aug. 13, 2015—Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.”
Apr. 2, 2015—The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011.
Mar. 12, 2015—Louis Staudt, M.D., Ph.D., a pioneer in gene expression profiling at the National Cancer Institute (NCI), will deliver the next Flexner Discovery Lecture on Thursday, March 19.
Jul. 15, 2014—The National Cancer Institute (NCI) is pleased to announce the Outstanding Investigator Award (OIA). The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for seven years to provide funding stability. NCI anticipates making about 50 awards annually. Vanderbilt may submit more than one application to this program, provided each is scientifically distinct. The OIA will allow funded investigators the freedom to embark on long-term projects of unusual potential in cancer research; the opportunity to take greater risks and be more adventurous in their lines of inquiry; and sufficient time to develop new techniques. The applicant PD/PI...
Nov. 14, 2013—The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall.
Feb. 28, 2013—Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.